Serial Number | 90085673 |
Word Mark | CB2 |
Filing Date | Friday, July 31, 2020 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, June 21, 2021 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of two letters, CB and a number, 2. |
Goods and Services | pharmaceuticals; pharmaceutical compositions; pharmaceutical preparations; pharmaceutical preparations that target and support the endocannabinoid system |
Pseudo Mark | CB TWO |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 31, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | 3D Medicine Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Newmarket, Ontario L3X1A3 CA |
Event Date | Event Description |
Monday, June 21, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, June 21, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Tuesday, December 8, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, December 8, 2020 | NON-FINAL ACTION E-MAILED |
Tuesday, December 8, 2020 | NON-FINAL ACTION WRITTEN |
Monday, December 7, 2020 | ASSIGNED TO EXAMINER |
Friday, November 27, 2020 | ASSIGNED TO EXAMINER |
Thursday, November 19, 2020 | ASSIGNED TO EXAMINER |
Monday, August 31, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Tuesday, August 4, 2020 | NEW APPLICATION ENTERED IN TRAM |